Therapeutic imatinib monitoring in patients with gastrointestinal stromal tumours.

被引：0
|
作者：
Spiliopoulou, Pavlina
Currie, Dawn
Haig, Caroline
Cowie, Fiona
White, Jeff D.
机构：
[1] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Inst Hlth & Wellbeing, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e22512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22512
引用
收藏
页数：2
相关论文
共 50 条
  • [41] MONTE-CARLO SIMULATIONS OF THE CLINICAL BENEFITS FROM THERAPEUTIC DRUG MONITORING OF SUNITINIB IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMOURS
    Goulooze, Sebastiaan
    Martin, Jennifer
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 4 - 4
  • [42] Golcic et al. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours.
    Golcic, Marin
    Jones, Robin L.
    Huang, Paul
    Napolitano, Andrea
    CANCERS, 2023, 15 (23)
  • [43] Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour
    Hompland, Ivar
    Bruland, Oyvind Sverre
    Ubhayasekhera, Kumari
    Bergquist, Jonas
    Boye, Kjetil
    CLINICAL SARCOMA RESEARCH, 2016, 6
  • [44] Gastrointestinal stromal tumours. (Br J Surg 2003; 90: 1178-1186)
    Neuhaus, SJ
    Clark, MA
    Thomas, JM
    Judson, I
    BRITISH JOURNAL OF SURGERY, 2004, 91 (01) : 126 - 126
  • [45] Tolerance of imatinib mesylate in chronic myeloid leukemia and gastrointestinal stromal tumours patients: an experience from India
    Mukhopadhyay, A
    Barman, B
    Sen, A
    Sarkar, S
    Gupta, P
    Deb, A
    Mukhopadhyay, S
    ANNALS OF ONCOLOGY, 2005, 16 : 304 - 304
  • [46] Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET
    Jager, PL
    Gietema, JA
    van der Graaf, WTA
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (05) : 433 - 438
  • [47] Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
    Yukinori Kurokawa
    Han-Kwang Yang
    Haruhiko Cho
    Min-Hee Ryu
    Toru Masuzawa
    Sook Ryun Park
    Sohei Matsumoto
    Hyuk-Joon Lee
    Hiroshi Honda
    Oh Kyoung Kwon
    Takashi Ishikawa
    Kyung Hee Lee
    Kazuhito Nabeshima
    Seong-Ho Kong
    Toshio Shimokawa
    Jeong-Hwan Yook
    Yuichiro Doki
    Seock-Ah Im
    Seiichi Hirota
    Seokyung Hahn
    Toshirou Nishida
    Yoon-Koo Kang
    British Journal of Cancer, 2017, 117 : 25 - 32
  • [48] Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations
    Wardelmann, E
    Thomas, N
    Merkelbach-Bruse, S
    Pauls, K
    Speidel, N
    Büttner, R
    Bihl, H
    Leutner, CC
    Heinicke, T
    Hohenberger, P
    LANCET ONCOLOGY, 2005, 6 (04): : 249 - 251
  • [49] Single Centre Experience of Neoadjuvant Imatinib for Unresectable or Recurrent Gastrointestinal Stromal Tumours
    Smith, Amy
    Beale, Philip
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 57 - 57
  • [50] Imatinib recommended as first post-surgery treatment for gastrointestinal stromal tumours
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (04) : 189 - 189
12345